Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

The problem with the new

Avoid being labelled either ‘risk taker’ or ‘Luddite’ by being a ‘considered adopter’

- PMLiVE

Janssen buys hepatitis C candidate from GSK

J&J subsidiary acquires rights to NS5A inhibitor

- PMLiVE

Bayer gets US nod for first-in-class Adempas

FDA clears drug for use in pulmonary artery hypertension

- PMLiVE

Lilly enters cancer collaboration in China

Signs deal with Chi-Med to develop and commercialise fruquintinib

- PMLiVE

Boehringer shuts Ben Venue unit

About 1,100 jobs expected to be lost at troubled manufacturing site

Acorda appoints new CFO

Michael Rodgers replaces David Lawrence who becomes chief business officer

- PMLiVE

Life restructure sees management reshuffle

Reg Manser leaves creative director post to take up chief creative officer role

- PMLiVE

Second thoughts – the science of decision making

Are you a rational person? Do you make choices based on appraisal of the facts and careful consideration of probability and statistics?

- PMLiVE

Beth Moore joins Saatchi & Saatchi Health

Moves from TBWAPW to take up new role as head of strategy

- PMLiVE

European R&D investment “stagnating”

Report says health research spend was flat in 2011

Bayer symbol

Bayer expects five drugs to enter phase III in 2015

Hopes to follow success of recent launches

- PMLiVE

GSK hoping to file malaria vaccine next year

New phase III data backs submission plans

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links